TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion
Open Access
- 1 January 2013
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 4 (7) , 566-572
Abstract
We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta-2; 3 fold induction) as a potential CD44-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates, collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA. Our results showed that TGF-β2 mRNA levels were significantly elevated following the removal of tetracycline at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-β2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tetracycline. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-β2 expression upon HA-stimulation, and subsequently inhibited BC cell invasion in vitro. In addition to identifying TGF-β2 as a target for HA/CD44 signaling, this data suggests that ATF/CREB might be a potential transcription factor linking HA/CD44 activation to TGF-β2 transcription and additional experiments are required for a better understanding of the molecular mechanisms underpinning the novel function of the CD44/ TGF-β2 signaling pathway in breast cancer metastasis.Keywords
This publication has 34 references indexed in Scilit:
- Tumor Necrosis Factor-α Regulates Transforming Growth Factor-β-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin InteractionJournal of Biological Chemistry, 2010
- Transforming Growth Factor-β1, Transforming Growth Factor-β2, and Transforming Growth Factor-β3 Enhance Ovarian Cancer Metastatic Potential by Inducing a Smad3-Dependent Epithelial-to-Mesenchymal TransitionMolecular Cancer Research, 2008
- CD44 Attenuates Metastatic Invasion during Breast Cancer ProgressionCancer Research, 2005
- Hyaluronan: from extracellular glue to pericellular cueNature Reviews Cancer, 2004
- Radiation and breast cancer: a review of current evidenceBreast Cancer Research, 2004
- Engagement of CD44 Promotes Rac Activation and CD44 Cleavage during Tumor Cell MigrationJournal of Biological Chemistry, 2004
- Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomasHistopathology, 2003
- Presenilin-dependent γ-secretase activity mediates the intramembranous cleavage of CD44Oncogene, 2003
- CD44 directs membrane‐type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin‐like domainThe EMBO Journal, 2002
- Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathwayJournal of Cell Biology, 2001